1. Albin H, Vincon G, Vincon J, Herrmann P, Thiercelin JP (1988) Study of the pharmacokinetics of zolpidem in healthy volunteers after repeated administration: effect on antipyrine clearance. In: Bartholini G, Friedmann JC, Sanger SZ, Morselli PL, Wick A (eds) Imidazopyridines in sleep disorders: a novel experimental and therapeutic approach. Raven Press, New York, pp 369–370
2. Balkin TJ, O'Donnell VM, Kamimori GH, Redmond DP, Belenky G (1989) Sleep inertia following triazolam-induced recovery sleep. Hum Psychopharmacol 4:291–296
3. Bonnet MH (1986) Performance and sleepiness as a function of frequency and placement of sleep disruption. Psychophysiology 23:263–271
4. Dennis T, Dubois A, Benavides J, Scatton B (1988) Distribution of central omega 1 (benzodiazepine 1; BZD1) and omega 2 (BZD2) receptor subtypes in the monkey and human brain: an autoradiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem. J Pharmacol Exp Ther 247:309–22
5. Dorian P, Sellers EM, Kaplan HL, Hamilton HL, Greenblatt DJ, Abernathy D (1985) Triazolam and ethanol interaction: kinetic and dynamic consequences. Clin Pharmacol Ther 37:558–562